Physic is, for the most part, only a substitute for temperance and exercise. - Joseph Addison

Drugs > Eloxatin (Oxaliplatin)

You are currently researching Oxaliplatin, below you will find the latest information on the subject of Oxaliplatin available at Drug Topics. Oxaliplatin is categorized in the O index of drugs (by medical name) and in E index of drugs (by common name).

The medical name for this drug is Oxaliplatin and the common name is Eloxatin.

Oxaliplatin (Eloxatin) News, Updated Regularly

High insulin levels increase breast cancer risk - Newstrack India
December 30, 2008, 11:11 pm

Washington, December 31 (ANI): An American study has revealed that high levels of insulin increase the risk of breast cancer in women. Lead researchers Marc Gunter and Howard Strickler, of the Albert Einstein College of Medicine in New York, revealed ...

Explaining Differences in Cisplatin and Oxaliplatin Ototoxicity - HULIQ.com
December 30, 2008, 2:07 pm

More cisplatin enters the inner ear in an animal model than oxaliplatin. The difference may explain why cisplatin treatment in humans can lead to hearing problems while oxaliplatin rarely does. The amount of cisplatin a patient can tolerate is often ...

Study sheds new light on chemotherapy drug-induced hearing damage - Thaindian.com
December 30, 2008, 10:07 pm

Washington, December 31 (ANI): Scientists at a leading European medical university have found out why chemotherapy using cisplatin often lead to hearing problems, but a treatment with oxaliplatin rarely does, despite both drugs being platinum ...

Reason Behind Chemotherapeutic Drug-Induced Hearing Damage Uncovered - Med India
January 1, 2009, 3:59 pm

Scientists at a leading European medical university have found out why chemotherapy using cisplatin often lead to hearing problems, but a treatment with oxaliplatin rarely does, despite both drugs being platinum compounds. A research team led by Dr ...

Also in the Dec. 30 JNCI - Genetic Engineering News
December 30, 2008, 1:53 pm

More cisplatin enters the inner ear in an animal model than oxaliplatin. The difference may explain why cisplatin treatment in humans can lead to hearing problems while oxaliplatin rarely does. The amount of cisplatin a patient can tolerate is often ...

Merck Serono: Study Published in JCO Shows Erbitux Enhances - PharmiWeb
January 5, 2009, 3:30 am

Darmstadt, January 05, 2009 ? A study published today in the Journal of Clinical Oncology demonstrates that the addition of Erbitux® (cetuximab) to standard oxaliplatin-based chemotherapy (FOLFOX-4) in previously untreated metastatic colorectal ...

Are you looking for additional Eloxatin (Oxaliplatin) news? Try our new "Oxaliplatin News Focus" area.

Are you looking for additional Eloxatin (Oxaliplatin) information? Try our new "Oxaliplatin Related Blog Entries" area.

Off-site Oxaliplatin (Eloxatin) Links, User Submitted

The following links have been collected through user bookmark submission in the Oxaliplatin_Eloxatin category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Thu Jul 17

Wed Jan 2

Sun Sep 24

Fri Sep 15

Mon Jul 24

Thu Mar 16

Off-site Oxaliplatin Research Links

If you still need additional information on Oxaliplatin then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Drug Index

If you are researching a particular drug and know its common name use the alphabetical links below to quickly navigate to your desired subject.


If you are researching a particular drug and know its medical name use the alphabetical links below to quickly navigate to your desired subject.

Recommended Drug Sites

The following drug sites are listed in alphabetical order.

Recommended Health Sites

The following health sites are listed in alphabetical order.

Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Drug-Topics.org was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.


Powered by Odin Assemble 2.5a